Literature DB >> 26461092

Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.

David L Schonberg1, Tyler E Miller1, Qiulian Wu1, William A Flavahan1, Nupur K Das2, James S Hale2, Christopher G Hubert1, Stephen C Mack1, Awad M Jarrar2, Robert T Karl3, Ann Mari Rosager4, Anne M Nixon5, Paul J Tesar3, Petra Hamerlik6, Bjarne W Kristensen4, Craig Horbinski7, James R Connor5, Paul L Fox2, Justin D Lathia2, Jeremy N Rich8.   

Abstract

Glioblastomas display hierarchies with self-renewing cancer stem-like cells (CSCs). RNA sequencing and enhancer mapping revealed regulatory programs unique to CSCs causing upregulation of the iron transporter transferrin, the top differentially expressed gene compared with tissue-specific progenitors. Direct interrogation of iron uptake demonstrated that CSCs potently extract iron from the microenvironment more effectively than other tumor cells. Systematic interrogation of iron flux determined that CSCs preferentially require transferrin receptor and ferritin, two core iron regulators, to propagate and form tumors in vivo. Depleting ferritin disrupted CSC mitotic progression, through the STAT3-FoxM1 regulatory axis, revealing an iron-regulated CSC pathway. Iron is a unique, primordial metal fundamental for earliest life forms, on which CSCs have an epigenetically programmed, targetable dependence.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26461092      PMCID: PMC4646058          DOI: 10.1016/j.ccell.2015.09.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  54 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Regulatory effects of ferritin on angiogenesis.

Authors:  Lan G Coffman; Derek Parsonage; Ralph D'Agostino; Frank M Torti; Suzy V Torti
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-06       Impact factor: 11.205

3.  Activation of the HIF prolyl hydroxylase by the iron chaperones PCBP1 and PCBP2.

Authors:  Anjali Nandal; Julio C Ruiz; Poorna Subramanian; Sudipa Ghimire-Rijal; Ruth Ann Sinnamon; Timothy L Stemmler; Richard K Bruick; Caroline C Philpott
Journal:  Cell Metab       Date:  2011-11-02       Impact factor: 27.287

4.  Acidic stress promotes a glioma stem cell phenotype.

Authors:  A B Hjelmeland; Q Wu; J M Heddleston; G S Choudhary; J MacSwords; J D Lathia; R McLendon; D Lindner; A Sloan; J N Rich
Journal:  Cell Death Differ       Date:  2010-12-03       Impact factor: 15.828

5.  Brain slice invasion model reveals genes differentially regulated in glioma invasion.

Authors:  Nikola Holtkamp; Anastasia Afanasieva; Anja Elstner; Frank K H van Landeghem; Matthias Könneker; Susanne A Kuhn; Helmut Kettenmann; Andreas von Deimling
Journal:  Biochem Biophys Res Commun       Date:  2005-11-04       Impact factor: 3.575

6.  Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts.

Authors:  J Graeme Hodgson; Ru-Fang Yeh; Amrita Ray; Nicholas J Wang; Ivan Smirnov; Mamie Yu; Sujatmi Hariono; Joachim Silber; Heidi S Feiler; Joe W Gray; Paul T Spellman; Scott R Vandenberg; Mitchel S Berger; C David James
Journal:  Neuro Oncol       Date:  2009-01-12       Impact factor: 12.300

7.  Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.

Authors:  Zhizhong Li; Shideng Bao; Qiulian Wu; Hui Wang; Christine Eyler; Sith Sathornsumetee; Qing Shi; Yiting Cao; Justin Lathia; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

8.  Pro- and anti-inflammatory cytokines during immune stimulation: modulation of iron status and red blood cell profile.

Authors:  A M Koorts; P F Levay; P J Becker; M Viljoen
Journal:  Mediators Inflamm       Date:  2011-03-24       Impact factor: 4.711

9.  A restricted cell population propagates glioblastoma growth after chemotherapy.

Authors:  Jian Chen; Yanjiao Li; Tzong-Shiue Yu; Renée M McKay; Dennis K Burns; Steven G Kernie; Luis F Parada
Journal:  Nature       Date:  2012-08-23       Impact factor: 49.962

10.  Forkhead box M1 (FoxM1) gene is a new STAT3 transcriptional factor target and is essential for proliferation, survival and DNA repair of K562 cell line.

Authors:  André L Mencalha; Renata Binato; Gerson M Ferreira; Barbara Du Rocher; Eliana Abdelhay
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more
  102 in total

1.  Glioblastoma Cancer Stem Cells Evade Innate Immune Suppression of Self-Renewal through Reduced TLR4 Expression.

Authors:  Alvaro G Alvarado; Praveena S Thiagarajan; Erin E Mulkearns-Hubert; Daniel J Silver; James S Hale; Tyler J Alban; Soumya M Turaga; Awad Jarrar; Ofer Reizes; Michelle S Longworth; Michael A Vogelbaum; Justin D Lathia
Journal:  Cell Stem Cell       Date:  2017-01-12       Impact factor: 24.633

2.  STAT3 Activation-Induced Fatty Acid Oxidation in CD8+ T Effector Cells Is Critical for Obesity-Promoted Breast Tumor Growth.

Authors:  Chunyan Zhang; Chanyu Yue; Andreas Herrmann; Jieun Song; Colt Egelston; Tianyi Wang; Zhifang Zhang; Wenzhao Li; Heehyoung Lee; Maryam Aftabizadeh; Yi Jia Li; Peter P Lee; Stephen Forman; George Somlo; Peiguo Chu; Laura Kruper; Joanne Mortimer; Dave S B Hoon; Wendong Huang; Saul Priceman; Hua Yu
Journal:  Cell Metab       Date:  2019-11-21       Impact factor: 27.287

3.  Combined proteomics/miRNomics of dendritic cell immunotherapy-treated glioblastoma patients as a screening for survival-associated factors.

Authors:  Friedrich Erhart; Matthias Hackl; Hannes Hahne; Johanna Buchroithner; Chen Meng; Simone Klingenbrunner; René Reitermaier; Katrin Fischhuber; Susanna Skalicky; Walter Berger; Sabine Spiegl-Kreinecker; Daniela Lötsch; Gerda Ricken; Bernhard Kuster; Adelheid Wöhrer; Georg Widhalm; Johannes Hainfellner; Thomas Felzmann; Alexander M Dohnal; Christine Marosi; Carmen Visus
Journal:  NPJ Vaccines       Date:  2020-01-16       Impact factor: 7.344

4.  Pharmacological Targeting of the Histone Chaperone Complex FACT Preferentially Eliminates Glioblastoma Stem Cells and Prolongs Survival in Preclinical Models.

Authors:  Josephine Kam Tai Dermawan; Masahiro Hitomi; Daniel J Silver; Qiulian Wu; Poorva Sandlesh; Andrew E Sloan; Andrei A Purmal; Katerina V Gurova; Jeremy N Rich; Justin D Lathia; George R Stark; Monica Venere
Journal:  Cancer Res       Date:  2016-02-26       Impact factor: 12.701

Review 5.  Iron and Cancer.

Authors:  Suzy V Torti; David H Manz; Bibbin T Paul; Nicole Blanchette-Farra; Frank M Torti
Journal:  Annu Rev Nutr       Date:  2018-08-21       Impact factor: 11.848

Review 6.  p53 tumor suppressor and iron homeostasis.

Authors:  Jin Zhang; Xinbin Chen
Journal:  FEBS J       Date:  2018-09-04       Impact factor: 5.542

7.  Assessing multiparametric drug response in tissue engineered tumor microenvironment models.

Authors:  Alexandra R Harris; Jessica X Yuan; Jennifer M Munson
Journal:  Methods       Date:  2017-12-16       Impact factor: 3.608

8.  MYC-Regulated Mevalonate Metabolism Maintains Brain Tumor-Initiating Cells.

Authors:  Xiuxing Wang; Zhi Huang; Qiulian Wu; Briana C Prager; Stephen C Mack; Kailin Yang; Leo J Y Kim; Ryan C Gimple; Yu Shi; Sisi Lai; Qi Xie; Tyler E Miller; Christopher G Hubert; Anne Song; Zhen Dong; Wenchao Zhou; Xiaoguang Fang; Zhe Zhu; Vaidehi Mahadev; Shideng Bao; Jeremy N Rich
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

9.  Treatment of glioblastoma using multicomponent silica nanoparticles.

Authors:  O Turan; P A Bielecki; V Perera; M Lorkowski; G Covarrubias; K Tong; A Yun; Georgia Loutrianakis; S Raghunathan; Y Park; T Moon; S Cooley; D Dixit; M A Griswold; K B Ghaghada; P M Peiris; J N Rich; E Karathanasis
Journal:  Adv Ther (Weinh)       Date:  2019-09-04

Review 10.  The role of iron homeostasis and iron-mediated ROS in cancer.

Authors:  Jia-Fu Ying; Ze-Bei Lu; Luo-Qin Fu; Yu Tong; Zhen Wang; Wei-Fen Li; Xiao-Zhou Mou
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.